|
Jeani Delagardelle is a Managing Director and primarily
concentrates on
medical device efforts. Jeani joined Sprout in August 2000
and became General Partner in July 2001. Previously, she was
a General Partner at Weiss, Peck & Greer Venture Partners
where she focused on healthcare/technology investments. Before joining
Weiss, Peck & Greer Venture Partners, Jeani spent 15 years
in senior marketing, sales, business development and general
manager positions in the healthcare industry. Specifically,
she was Vice President of Global Marketing for Target
Therapeutics (acquired by Boston Scientific for $1.1B) and
spent nine years with the Medi-tech division of Boston
Scientific in several senior management roles. In addition,
Jeani served as Director of Business Operations for Roche
Laboratories and Director of Global Marketing for Cell Pro,
Inc. Jeani attended University of California at Irvine (MBA)
and Occidental College (AB). Jeani leads the medical device
investment effort.
Board Seats:
Access Closure,
Aspire Medical,
Direct Flow,
Intrinsic Therapeutics,
ReShape Medical,
Spiration,
Visiogen
Contact Information:
jeani@nlvpartners.com
(650) 234-2700
|
 |
